IMVT — IMMUNOVANT INC

Ownership history in Bridgefront Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Bridgefront Capital, LLC reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.18% (2025 Q1)
Avg. % of fund
0.1%
First filed
2021 Q2
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 13,654 -7,067 -34.1% 0.06% $220K $16.12
2025 Q2 REDUCED 20,721 -15,338 -42.5% 0.09% $332K $16.00
2025 Q1 ADDED 36,059 +20,410 +130.4% 0.18% $616K $17.09
2022 Q2 REDUCED 15,649 -3,353 -17.6% 0.07% $61K $3.90
2022 Q1 ADDED 19,002 +5,390 +39.6% 0.13% $105K $5.51
2021 Q2 INITIATED 13,612 — — 0.05% $144K $10.57
% of Fund (quarterly)    IMVT price (monthly, adj. close)

Other funds also holding IMVT

As of 2025 Q4 — sorted by position size

Alpine Global Management, LLC 3Y 7Y 11.36% GREAT POINT PARTNERS LLC 3Y 7Y 6.18% Deep Track Capital, LP 3Y 5.22% ADAR1 Capital Management, LLC 4.57% SUPERSTRING CAPITAL MANAGEMENT LP 3.93% STEMPOINT CAPITAL LP 2.81% Logos Global Management LP 3Y 2.11% Exome Asset Management LLC 1.93% ARMISTICE CAPITAL, LLC 3Y 7Y 1.74% Two Seas Capital LP 3Y 1.5%
← Back to Bridgefront Capital, LLC Holdings